Annual Cash & Cash Equivalents
$92.65 M
+$46.97 M+102.81%
December 1, 2024
Summary
- As of March 12, 2025, VERA annual cash & cash equivalents is $92.65 million, with the most recent change of +$46.97 million (+102.81%) on December 1, 2024.
- During the last 3 years, VERA annual cash & cash equivalents has risen by +$12.97 million (+16.28%).
- VERA annual cash & cash equivalents is now at all-time high.
Performance
VERA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$92.65 M
+$65.39 M+239.91%
December 1, 2024
Summary
- As of March 12, 2025, VERA quarterly cash and cash equivalents is $92.65 million, with the most recent change of +$65.39 million (+239.91%) on December 1, 2024.
- Over the past year, VERA quarterly cash and cash equivalents has stayed the same.
- VERA quarterly cash and cash equivalents is now -32.56% below its all-time high of $137.38 million, reached on March 31, 2023.
Performance
VERA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VERA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +102.8% | 0.0% |
| 3 y3 years | +16.3% | 0.0% |
| 5 y5 years | +2799.7% | 0.0% |
VERA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.2% | -32.6% | +269.3% |
| 5 y | 5-year | at high | +2799.7% | -32.6% | +2538.1% |
| alltime | all time | at high | +2799.7% | -32.6% | +2538.1% |
Vera Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $92.65 M(+102.8%) | $92.65 M(+239.9%) |
| Sep 2024 | - | $27.26 M(+8.7%) |
| Jun 2024 | - | $25.09 M(-63.7%) |
| Mar 2024 | - | $69.11 M(+51.3%) |
| Dec 2023 | $45.68 M(+5.1%) | $45.68 M(+66.5%) |
| Sep 2023 | - | $27.44 M(-19.0%) |
| Jun 2023 | - | $33.89 M(-75.3%) |
| Mar 2023 | - | $137.38 M(+216.1%) |
| Dec 2022 | $43.46 M | $43.46 M(+42.6%) |
| Sep 2022 | - | $30.48 M(-39.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $50.43 M(-54.8%) |
| Mar 2022 | - | $111.51 M(+40.0%) |
| Dec 2021 | $79.67 M(+48.5%) | $79.67 M(-7.6%) |
| Sep 2021 | - | $86.19 M(-5.9%) |
| Jun 2021 | - | $91.63 M(+85.1%) |
| Mar 2021 | - | $49.51 M(-7.7%) |
| Dec 2020 | $53.65 M(+1579.3%) | - |
| Dec 2020 | - | $53.65 M(-1511.9%) |
| Mar 2020 | - | -$3.80 M |
| Dec 2019 | $3.19 M | - |
FAQ
- What is Vera Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vera Therapeutics?
- What is Vera Therapeutics annual cash & cash equivalents year-on-year change?
- What is Vera Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vera Therapeutics?
- What is Vera Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Vera Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of VERA is $92.65 M
What is the all time high annual cash & cash equivalents for Vera Therapeutics?
Vera Therapeutics all-time high annual cash & cash equivalents is $92.65 M
What is Vera Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, VERA annual cash & cash equivalents has changed by +$46.97 M (+102.81%)
What is Vera Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VERA is $92.65 M
What is the all time high quarterly cash and cash equivalents for Vera Therapeutics?
Vera Therapeutics all-time high quarterly cash and cash equivalents is $137.38 M
What is Vera Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, VERA quarterly cash and cash equivalents has changed by $0.00 (0.00%)